Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0406810 (
NAME
)
13,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
New methodology approaches with a broad coverage of the biological effects are urgently needed to evaluate the safety of the universe of environmentally relevant chemicals. Here, we propose a tiered approach incorporating transcriptomics and
in vitro
bioassays to assess environmental mixtures. The mixture samples and the perturbed biological pathways are prioritized by concentration-dependent transcriptome (CDT) and then used to guide the selection of
in vitro
bioassays for toxicant identification. To evaluate omics' screening capability, we first applied a CDT technique to test mixture samples by HepG2 and MCF7 cells. The effect recoveries of large-volume solid-phase extraction on the overall bioactivity of the mixture were 48.9% in HepG2 and 58.3% in MCF7. The overall bioactivity potencies obtained by transcriptomics were positively correlated with the panel of 8 bioassays among 14 mixture samples combined with the previous data. Transcriptomics could predict their activation status (AUC = 0.783) and the relative potency (
p
< 0.05) of bioassays for four of the eight receptors (
AhR
,
ER
,
AR
, and
Nrf2
). Furthermore, the CDT identified other biological pathways perturbated by mixture samples, such as the pathway related to
TP53
,
CAR
,
FXR
,
HIF
,
THRA
, etc. Overall, this study demonstrates the potential of concentration-dependent omics for effect-based water quality assessment.
...
PMID:A Tiered Approach for Screening and Assessment of Environmental Mixtures by Omics and
In Vitro
Assays. 3240 3